Apr 20, 2020 7:30am EDT Tonix Pharmaceuticals to Deliver Virtual Presentation and Participate in Panel Discussion for Planet MicroCap Showcase Virtual Investor Conference 2020
Mar 24, 2020 5:15pm EDT Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
Mar 23, 2020 4:30pm EDT Tonix Pharmaceuticals to Deliver Virtual Presentation for Spring Investor Summit
Mar 3, 2020 5:00pm EST Tonix Pharmaceuticals Holding Corp. Closes $16,005,000 Common Stock Registered Direct Offering
Feb 28, 2020 8:45am EST Tonix Pharmaceuticals, Inc. Prices $16,005,000 Common Stock Offering Priced At-The-Market
Feb 26, 2020 7:00am EST Tonix Pharmaceuticals Announces Research Collaboration with Southern Research to Develop a Potential Vaccine to Protect Against New Coronavirus Disease 2019 (COVID-19) Based on Horsepox Virus (TNX-1800)
Feb 5, 2020 5:15pm EST Tonix Pharmaceuticals Announces Outcome of Interim Analysis for Phase 3 RECOVERY Study of Tonmya® (TNX-102 SL) in PTSD
Feb 4, 2020 7:00am EST Tonix Pharmaceuticals to Participate in Upcoming February Investor Conferences
